MERIT MEDICAL SYSTEMS INC MMSI
MERIT MEDICAL SYSTEMS INC (MMSI) earns a Piotroski F-score of 7/9 (strong financial health), with an Altman Z″ in the safe zone. It does not currently pay a dividend. FY2025 revenue was $1.5B at a 8.5% net margin.
Quality score trend · recomputed for each fiscal year
Each year's score is computed from that year's filing — a rising Piotroski F or Altman Z″ means improving financial health, a fall is worth a look.
Beneish M-score: -2.72 — low (below −2.22 — no manipulation red flag) . A statistical screen for earnings manipulation, not proof — and it doesn't apply to most banks/insurers.
Analyst price target
Recent analyst actions
| Date | Firm | Rating |
|---|---|---|
| 2026-05-01 | Canaccord Genuity | Buy (main) |
| 2026-05-01 | JP Morgan | Overweight (main) |
| 2026-05-01 | Wells Fargo | Equal-Weight (main) |
| 2026-05-01 | Needham | Buy (main) |
| 2026-04-20 | Barrington Research | Outperform (main) |
| 2026-04-17 | Piper Sandler | Overweight (main) |
Wall Street analyst consensus — a sentiment gauge, not our scoring.
How it ranks in Manufacturing · percentile among 1957 companies
Percentile vs other Manufacturing companies we cover — e.g. “stronger than 90%” means only 10% score higher on that measure.
Piotroski F breakdown · 7/9 tests passed
- Positive return on assets
- Positive operating cash flow
- Rising ROA
- Cash flow exceeds net income
- Lower long-term debt
- Rising current ratio
- No share dilution
- Rising gross margin
- Rising asset turnover
Altman Z″ components · safe zone
| Component | Value |
|---|---|
| Working capital / assets | 0.298 |
| Retained earnings / assets | 0.307 |
| EBIT / assets | 0.069 |
| Equity / liabilities | 1.438 |
Sector peers · similar-size Manufacturing companies compare side by side →
| Ticker | Company | Piotroski F | Altman Z″ | P / E | Revenue growth |
|---|---|---|---|---|---|
| MMSI | MERIT MEDICAL SYSTEMS INC | 7/9 | 4.93 | 33.3 | +11.8% |
| PEN | Penumbra Inc | 6/9 | 8.59 | 70.1 | +17.5% |
| IART | INTEGRA LIFESCIENCES HOLDINGS CORP | 5/9 | 1.17 | — | +1.5% |
| HAE | HAEMONETICS CORP | 7/9 | 2.85 | 36.1 | -2% |
| EMBC | Embecta Corp. | 6/9 | 1.99 | 2.2 | -3.8% |
| TFX | TELEFLEX INC | 5/9 | 3.56 | — | +17.2% |
| TNDM | TANDEM DIABETES CARE INC | 3/9 | -3.04 | — | +7.9% |
About MERIT MEDICAL SYSTEMS INC
Merit Medical Systems, Inc. designs, develops, manufactures, and markets single-use medical products for interventional, diagnostic, and therapeutic procedures in the United States, China, Japan, Germany, France, the United Kingdom, and internationally. It operates through two segments, Cardiovascular and Endoscopy. The company offers micropuncture kits, angiographic needles, sheaths, guide wires, and safety products; peripheral intervention products comprising angiography, drainage, delivery systems, and embolotherapy products; oncology products, such as soft tissue biopsy products and accessories; cardiac intervention products consisting of cardiac access, angiography, electrophysiology and cardiac rhythm management, fluid management, hemodynamic monitoring, hemostasis, and intervention products; and spine products, including vertebral augmentation, radiofrequency ablation, and bone biopsy systems. It also provides custom procedural solutions, including critical care products, syringes, manifold kits, and trays and packs; coating services for medical tubes and wires; and sensor components for microelectromechanical systems. In addition, the company offers gastroenterology products, such as esophageal stents, cryoballoon and inflation devices, gauges, and balloon dilators; pulmonary products consisting of laser-cut tracheobronchial stents, and over-the-wire and direct visualization delivery systems; and kits and accessories for endoscopy and bronchoscopy procedures. It sells its products to hospitals, alternate site-based physicians, technicians, and nurses through direct sales force, independent distributors, original equipment manufacturer partners, and custom procedure tray manufacturers. The company exports its products to Canada, Western Europe, Australia, Brazil, Malaysia, South Korea, the United Arab Emirates, India, New Zealand, and South Africa. Merit Medical Systems, Inc. was incorporated in 1987 and is headquartered in South Jordan, Utah.
FAQ
Is MMSI financially healthy?
MERIT MEDICAL SYSTEMS INC's Piotroski F-score is 7/9 (8–9 is excellent, 0–3 weak), and its Altman Z″ distress score is in the safe zone.
Does MMSI pay a dividend?
No, MERIT MEDICAL SYSTEMS INC does not currently pay a dividend.
How profitable is MMSI?
In FY2025, MERIT MEDICAL SYSTEMS INC had a net margin of 8.5% and a return on equity of 8.1%.
Is MMSI overvalued or undervalued?
MERIT MEDICAL SYSTEMS INC trades at about 42.8× trailing earnings — below its 10-year norm (10-year range 31.2×–364.2×, median 56.4×). Stocktoria reports the data, not buy/sell advice.
What is the analyst price target for MMSI?
The average Wall-Street price target for MERIT MEDICAL SYSTEMS INC is $89.55, about 1.8% below the recent price, from 11 analysts.
Is MMSI a good stock to buy?
Stocktoria doesn't give buy or sell advice, but here is the data on MERIT MEDICAL SYSTEMS INC: a Piotroski F-score of 7/9, an Altman Z″ in the safe zone, a P/E of about 33.3×. Weigh these quality and valuation signals against your own goals.
Computed from company filings · US · as of 2025-12-31. Facts plus Stocktoria's own computed scores — not investment advice.